Pandemic News and Research RSS Feed - Pandemic News and Research

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.
University of Adelaide-led project develops new test to eradicate H5N1 bird flu

University of Adelaide-led project develops new test to eradicate H5N1 bird flu

A University of Adelaide-led project has developed a new test that can distinguish between birds that have been vaccinated against the H5N1 strain of avian influenza virus or "bird flu" with those that have been naturally infected. [More]
Insilico Medicine, CCARL and Plantbiosis partner to advance research on aging

Insilico Medicine, CCARL and Plantbiosis partner to advance research on aging

Through this unique partnership, the Baltimore-based Insilico Medicine and Lethbridge-based CCARL will provide expertise in aging research and build on the personalized medicine and drug discovery platforms OncoFinder and GeroScope to develop new systems for age-related diseases. [More]
Study details crucial role of culture in achieving better health

Study details crucial role of culture in achieving better health

The systematic neglect of culture is the single biggest barrier to advancing the highest attainable standard of health worldwide, say the authors of a major new report on culture and health, led by Professor David Napier, a leading medical anthropologist from University College London (UCL), UK, and published in The Lancet. [More]
Imaxio awarded ANR funding to improve efficacy of vaccines for seasonal influenza

Imaxio awarded ANR funding to improve efficacy of vaccines for seasonal influenza

Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has been awarded funding of EUR 600,000 (USD 772,000) by the French National Research Agency (Agence Nationale de la Recherche, ANR) for the OPTIVAC project 'leveraging On t-cell immune resPonse To Improve influenza VACcines'. [More]
Views on Ebola: America needs to 'calm down'; political criticism is off base

Views on Ebola: America needs to 'calm down'; political criticism is off base

A Texas university refuses to accept students from Nigeria, where there were a couple dozen Ebola cases before the disease was quickly stopped. [More]
Scientific insights into flu viruses must not give way to complacency, say researchers

Scientific insights into flu viruses must not give way to complacency, say researchers

As our ability to assess the pandemic risk from strains of influenza virus increases with the latest scientific developments, we must not allow ourselves to become complacent that the most substantial threats have been identified, argue an international consortium of scientists. [More]
Females' natural resistance to bacterial pneumonia is linked to NOS3 enzyme

Females' natural resistance to bacterial pneumonia is linked to NOS3 enzyme

Researchers have linked increased resistance to bacterial pneumonia in female mice to an enzyme activated by the female sex hormone estrogen. [More]
Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Kalorama Information believes an experimental vaccine distribution in the United Kingdom and other similar developments point to a growing flu vaccine market, as well as a growing market for the production of these vaccines. [More]
Views on Ebola: Try to keep 'an even keel'; who's in charge of fighting a pandemic?

Views on Ebola: Try to keep 'an even keel'; who's in charge of fighting a pandemic?

Understandably, the specter of such a dangerous disease in the United States has bred fear. But it is remarkable how some public figures are inflaming that fear. Commentator Rush Limbaugh took flight on Tuesday, saying on the radio that "I don't think anybody involved with Ebola knows what they're doing. I don't care if it's the WHO or the Centers for Disease Control, I don't think anybody knows what they're doing." This was an unfounded rant that can only deepen public disquiet. [More]
Viewpoints: Health law opposition not propelling GOP; keep politics out of the fight against Ebola

Viewpoints: Health law opposition not propelling GOP; keep politics out of the fight against Ebola

As recently as April, Obamacare was going to be the silver bullet for Republicans in this year's midterm elections. The leader of conservative advocacy group Americans for Prosperity said his plan was to make Obamacare "the No. 1 issue in the country." Senate Minority Leader Mitch McConnell, R-Ky., declared that the law would be "a huge disaster in 2014" and the deciding factor in November. Well, that was then. Now, three weeks from Election Day, some GOP challengers trying to knock off Democratic incumbent senators have scaled back their anti-Obamacare ads in favor of new targets such as the economy and national security (10/13). [More]
MSH mobilizes resources to strengthen Liberia’s health system, limit spread of Ebola

MSH mobilizes resources to strengthen Liberia’s health system, limit spread of Ebola

Management Sciences for Health (MSH), a Massachusetts-based global health nonprofit organization, today announced it is mobilizing its expertise and resources at the epicenter of the Ebola epidemic in Liberia to help the Ministry of Health develop community care centers for Ebola separate from the health facilities; restore essential health services for non-Ebola patients; and, improve the detection and containment of active Ebola cases in Liberian communities. [More]
TGen, NAU awarded patent for genomics-based test to detect H1N1 pandemic flu strain

TGen, NAU awarded patent for genomics-based test to detect H1N1 pandemic flu strain

The federal government has awarded a patent to the Translational Genomics Research Institute and Northern Arizona University for a test that can detect — and assist in the treatment of — the H1N1 pandemic flu strain. [More]
Study: H7N9 flu vaccine combined with adjuvant is essential to promote protective immune response

Study: H7N9 flu vaccine combined with adjuvant is essential to promote protective immune response

A large, NIH-sponsored clinical trial of an experimental H7N9 avian influenza vaccine found an immune response that was believed to be protective in 59 percent of study participants who received two injections of the inactivated vaccine at the lowest dosage tested when mixed with an adjuvant – a component that boosts the body's immune response and enhances the effectiveness of inactivated influenza vaccines. [More]
Two randomized trials examine new vaccination strategies for avian influenza

Two randomized trials examine new vaccination strategies for avian influenza

Two randomized trials in the October 8 issue of JAMA examine new vaccination strategies for the prevention and control of avian influenza, often referred to as "bird flu." This is a theme issue on infectious disease. [More]
UW-Madison's Yoshihiro Kawaoka recognized for efforts to prevent pandemic influenza

UW-Madison's Yoshihiro Kawaoka recognized for efforts to prevent pandemic influenza

The University of Wisconsin-Madison's Yoshihiro Kawaoka has been recognized as a 2014 Popular Mechanics Breakthrough Award recipient for his efforts to understand and prevent pandemic influenza. [More]
Free online service launched to alert U.S. residents about new potential Ebola cases in nearby area

Free online service launched to alert U.S. residents about new potential Ebola cases in nearby area

EbolaScan.com launched today, bringing the power of local online alerts to U.S. residents concerned about new potential Ebola cases in their area. The free service, available via the web, tablets, and smartphones, alerts people with information about the latest reported cases nearby. [More]
Genetic history of HIV finally unravelled

Genetic history of HIV finally unravelled

Research, published today, shows that the HIV pandemic almost certainly began its global spread in the 1920s in Kinshasa in the Democratic Republic of Congo. [More]
UAE calls for strengthening global campaign to eradicate polio

UAE calls for strengthening global campaign to eradicate polio

At an event hosted by the UAE Ministry of International Cooperation and Development, speaking on behalf of the Minister MICAD, HE Sheikha Lubna Bint Khaled Al Qasimi, HE Dr. Anwar Gargash, Minister of State for Foreign Affairs and Minister of State for Federal National Council Affairs, called for an intensification of the global campaign to eradicate polio. [More]
CDC urges all adults to get flu vaccination

CDC urges all adults to get flu vaccination

Influenza vaccination coverage estimates show an encouraging upward trend overall, but coverage among healthy 18 to 64 year-olds has yet to top 40 percent, according to new data announced at a news conference held today by the National Foundation for Infectious Diseases. [More]
Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has been awarded a contract valued at up to $24.7 million inclusive of options by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID). [More]